InsidersTradesSigma
Follow the 테라젠이텍스 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 테라젠이텍스 has logged 12 public disclosures. Market capitalisation: €72bn. The latest transaction was disclosed on 19 March 2026 (Purchase). Among the most active insiders: 테라젠이텍스. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
12 of 12 declarations
Teragen Etex is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions in the biotechnology field.